Subcomplexes of human ATP synthase mark mitochondrial biosynthesis disorders

被引:66
作者
Carrozzo, R
Wittig, I
Santorelli, FM
Bertini, E
Hofmann, S
Brandt, U
Schägger, H
机构
[1] Bambino Gesu Pediat Hosp, Unit Mol Med, Rome, Italy
[2] Res Inst, Rome, Italy
[3] Univ Frankfurt, Zentrum Biol Chem Mol Bioenerget, D-6000 Frankfurt, Germany
[4] Acad Hosp Munich Schwabing, Diabet Res Inst, Munich, Germany
关键词
D O I
10.1002/ana.20729
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Methods: We describe biochemically and clinically relevant aspects of mitochondrial ATP synthase, the enzyme that supplies most ATP for the cells energy demand. Results: Analyzing human Rho zero cells we could identify three subcomplexes of ATP synthase. F-1 catalytic domain, F-1 domain with bound natural IF1 inhibitor protein, and F-1-c subcomplex, an assembly of F-1 domain and a ring of F-O-subunits c. Large amounts of F-1 subcomplexes accumulated also in mitochondria of patients with specific mitochondrial disorders. By quantifying the F, subcomplexes and other oxidative phosphorylation complexes in parallel, we were able to discriminate three classes of defects in mitochondrial biosynthesis, namely, mitochondrial DNA depletion, mitochondrial transfer RNA (tRNA) mutations, and mutations in the mitochondrial ATP6 gene. Intetpretation: The relatively simple electrophoretic assay used here is a straightforward approach to differentiate between various types of genetic alterations affecting the biosynthesis of oxidative phosphorylation complexes and will be useful to guide molecular genetic diagnostics in the field of mitochondrial neuromuscular disorders.
引用
收藏
页码:265 / 275
页数:11
相关论文
共 47 条
[1]   STRUCTURE AT 2.8-ANGSTROM RESOLUTION OF F1-ATPASE FROM BOVINE HEART-MITOCHONDRIA [J].
ABRAHAMS, JP ;
LESLIE, AGW ;
LUTTER, R ;
WALKER, JE .
NATURE, 1994, 370 (6491) :621-628
[2]  
[Anonymous], MEMBRANE PROTEIN PUR
[3]   The ATP synthase - A splendid molecular machine [J].
Boyer, PD .
ANNUAL REVIEW OF BIOCHEMISTRY, 1997, 66 :717-749
[4]   Modulation of the oligomerization state of the bovine F1-ATPase inhibitor protein, IF1, by pH [J].
Cabezon, E ;
Butler, PJG ;
Runswick, MJ ;
Walker, JE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (33) :25460-25464
[5]   The structure of bovine F1-ATPase in complex with its regulatory protein IF1 [J].
Cabezón, E ;
Montgomery, MG ;
Leslie, AGW ;
Walker, JE .
NATURE STRUCTURAL BIOLOGY, 2003, 10 (09) :744-750
[6]   Mutation Analysis in 16 Patients With mtDNA Depletion [J].
Carrozzo, R. ;
Bornstein, B. ;
Lucioli, S. ;
Campos, Y. ;
de la Pena, P. ;
Petit, N. ;
Dionisi-Vici, C. ;
Vilarinho, L. ;
Rizza, T. ;
Bertini, E. ;
Garesse, R. ;
Santorelli, F. M. ;
Arenas, J. .
HUMAN MUTATION, 2003, 21 (04) :453-454
[7]   The T9176G mtDNA mutation severely affects ATP production and results in Leigh syndrome [J].
Carrozzo, R ;
Tessa, A ;
Vázquez-Memije, ME ;
Piemonte, F ;
Patrono, C ;
Malandrini, A ;
Dionisi-Vici, C ;
Vilarinho, L ;
Villanova, M ;
Schägger, H ;
Federico, A ;
Bertini, E ;
Santorelli, F .
NEUROLOGY, 2001, 56 (05) :687-690
[8]   Mutant mitochondrial elongation factor G1 and combined oxidative phosphorylation deficiency [J].
Coenen, MJH ;
Antonicka, H ;
Ugalde, C ;
Sasarman, F ;
Rossi, R ;
Heister, JGAMA ;
Newbold, RF ;
Trijbels, FJMF ;
van den Heuvel, LP ;
Shoubridge, EA ;
Smeitink, JAM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (20) :2080-2086
[9]   Genetic heterogeneity in Leigh syndrome [J].
DiMauro, S ;
DeVivo, DC .
ANNALS OF NEUROLOGY, 1996, 40 (01) :5-7
[10]  
ERNSTER L, 1986, METHOD ENZYMOL, V126, P428